Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.

Background: In order to identify biomarkers involved in breast cancer, gene expression profiling was conducted using human breast cancer tissues.Methods: Total RNAs were extracted from 150 clinical patient tissues covering three breast cancer subtypes (Luminal A, Luminal B, and Triple negative) as w...

Descripción completa

Detalles Bibliográficos
Publicado en:BMC Cancer Vol. 15; no. 1; pp. 473 - 474
Autores principales: Fu, Junjie, Khaybullin, Ravil, Zhang, Yanping, Xia, Amy, Qi, Xin
Formato: research Journal Article
Publicado: BioMed Central 2015
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=109584807&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 109584807
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        14712407
        1CH9
      jtl: BMC Cancer
      issn: 14712407
      maglogo: N
    pubinfo:
      dt: 2015
      vid: 15
      iid: 1
      pid: 24147
      pub: BioMed Central
    artinfo:
      ui:
        109584807
        109584807
        NLM26084486
        2013060816
        10.1186/s12885-015-1410-y
        NLM26084486
        PMC4477316
        109584807
      ppf: 473
      ppct: 1
      formats:
      tig:
        atl: Gene expression profiling leads to discovery of correlation of matrix metalloproteinase 11 and heparanase 2 in breast cancer progression.
      aug:
        au:
          Fu, Junjie
          Khaybullin, Ravil
          Zhang, Yanping
          Xia, Amy
          Qi, Xin
      sug:
      ab: Background: In order to identify biomarkers involved in breast cancer, gene expression profiling was conducted using human breast cancer tissues.Methods: Total RNAs were extracted from 150 clinical patient tissues covering three breast cancer subtypes (Luminal A, Luminal B, and Triple negative) as well as normal tissues. The expression profiles of a total of 50,739 genes were established from a training set of 32 samples using the Agilent Sure Print G3 Human Gene Expression Microarray technology. Data were analyzed using Agilent Gene Spring GX 12.6 software. The expression of several genes was validated using real-time RT-qPCR.Results: Data analysis with Agilent GeneSpring GX 12.6 software showed distinct expression patterns between cancer and normal tissue samples. A group of 28 promising genes were identified with ≥ 10-fold changes of expression level and p-values < 0.05. In particular, MMP11 and HPSE2 were closely examined due to the important roles they play in cancer cell growth and migration. Real-time RT-qPCR analyses of both training and testing sets validated the gene expression profiles of MMP11 and HPSE2.Conclusions: Our findings identified these 2 genes as a novel breast cancer biomarker gene set, which may facilitate the diagnosis and treatment in breast cancer clinical therapies.
      pubtype: Academic Journal
      doctype:
        research
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N